Regulation of vascular smooth muscle cell autophagy by DNA nanotube-conjugated mTOR siRNA

Biomaterials

Volumn 67, Issue , 2015, Pages 137-150

  You, Zaichun ^a,b   Qian, Hang ^c   Wang, Changzheng ^a   He, Binfeng ^a   Yan, Jiawei ^c   Mao, Chengde ^d   Wang, Guansong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Xinqiao Hospital   (China)

^c XIAMEN UNIVERSITY   (China)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Anoxia; Autophagy; DNA nanostructures; DNA nanotubes; MTOR; Self assembly; SiRNA

Indexed keywords

ANTIBIOTICS; CELL DEATH; CELL PROLIFERATION; DISEASE CONTROL; DNA; GENE THERAPY; MAMMALS; MOLECULAR BIOLOGY; NANOTUBES; SELF ASSEMBLY;

ANOXIA; AUTOPHAGY; DNA NANOSTRUCTURES; DNA NANOTUBES; MTOR; SIRNA;

MUSCLE;

MAMMALIAN TARGET OF RAPAMYCIN; NANOCARRIER; NANOTUBE; SELF ASSEMBLED DNA NANOTUBE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CYCLINE; DNA; MICROTUBULE ASSOCIATED PROTEIN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; AUTOPHAGY; CELL GROWTH; CELL HYPOXIA; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; NANOPHARMACEUTICS; PRIORITY JOURNAL; PULMONARY ARTERIAL SMOOTH MUSCLE CELL; PULMONARY ARTERY MUSCLE; VASCULAR SMOOTH MUSCLE CELL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; GENETIC TRANSFECTION; METABOLISM; PHAGOSOME; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE;

MAMMALIA;

AUTOPHAGY; CELL DEATH; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; DNA; ENDOCYTOSIS; FLOW CYTOMETRY; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NANOTUBES; PHAGOSOMES; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRANSFECTION;

EID: 84939619089     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.07.015     Document Type: Article

References (80)

1. Sun H., Meng F., Dias A.A., Hendriks M., Feijen J., Zhong Z. alpha-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applications. Biomacromolecules 2011, 12:1937-1955.
2. Dane E.L., Chin S.L., Grinstaff M.W. Synthetic enantiopure carbohydrate polymers that are highly soluble in water and noncytotoxic. ACS Macro Lett. 2013, 2:887-890.
3. Lonez C., Vandenbranden M., Ruysschaert J.M. Cationic lipids activate intracellular signaling pathways. Adv. Drug Deliv. Rev. 2012, 64:1749-1758.
4. Savarala S., Brailoiu E., Wunder S.L., Ilies M.A. Tuning the self-assembling of pyridinium cationic lipids for efficient gene delivery into neuronal cells. Biomacromolecules 2013, 14:2750-2764.
5. de Faria P.C., dos Santos L.I., Coelho J.P., Ribeiro H.B., Pimenta M.A., Ladeira L.O., et al. Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8(+) T cell response and protection against cancer. Nano Lett. 2014, 14:5458-5470.
6. Mulvey J.J., Villa C.H., McDevitt M.R., Escorcia F.E., Casey E., Scheinberg D.A. Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery. Nat. Nanotechnol. 2013, 8:763-771.
7. Burg T.P., Godin M., Knudsen S.M., Shen W., Carlson G., Foster J.S., et al. Weighing of biomolecules, single cells and single nanoparticles in fluid. Nature 2007, 446:1066-1069.
8. Zhang Y., Friedlander R.M. Using non-coding small RNAs to develop therapies for Huntington's disease. Gene Ther. 2011, 18:1139-1149.
9. van der Wiel I.M., Cheng J., Koukiekolo R., Lyn R.K., Stevens N., O'Connor N., et al. FLEth RNA intercalating probe is a convenient reporter for small interfering RNAs. J. Am. Chem. Soc. 2009, 131:9872-9873.
10. Miura N., Shimizu M., Shinoda W., Tsuno S., Sato R., Wang X., et al. Human RGM249-derived small RNAs potentially regulate tumor malignancy. Nucleic Acid. Ther. 2013, 23:332-343.
11. Hu Q.D., Tang G.P., Chu P.K. Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications. Acc. Chem. Res. 2014, 47:2017-2025.
12. Schatz C., Louguet S., Le Meins J.F., Lecommandoux S. Polysaccharide-block-polypeptide copolymer vesicles: towards synthetic viral capsids. Angew. Chem. Int. Ed. Engl. 2009, 48:2572-2575.
13. Dedeo M.T., Finley D.T., Francis M.B. Viral capsids as self-assembling templates for new materials. Prog. Mol. Biol. Transl. Sci. 2011, 103:353-392.
14. Li J., Fan C., Pei H., Shi J., Huang Q. Smart drug delivery nanocarriers with self-assembled DNA nanostructures. Adv. Mater. 2013, 25:4386-4396.
15. Jiang Q., Song C., Nangreave J., Liu X., Lin L., Qiu D., et al. DNA origami as a carrier for circumvention of drug resistance. J. Am. Chem. Soc. 2012, 134:13396-13403.
16. Wang Z.G., Ding B. Engineering DNA self-assemblies as templates for functional nanostructures. Acc. Chem. Res. 2014, 47:1654-1662.
17. Lee H., Lytton-Jean A.K., Chen Y., Love K.T., Park A.I., Karagiannis E.D., et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 2012, 7:389-393.
18. Walsh A.S., Yin H., Erben C.M., Wood M.J., Turberfield A.J. DNA cage delivery to mammalian cells. ACS Nano 2011, 5:5427-5432.
19. Erben C.M., Goodman R.P., Turberfield A.J. Single-molecule protein encapsulation in a rigid DNA cage. Angew. Chem. Int. Ed. Engl. 2006, 45:7414-7417.
20. Ko S., Liu H., Chen Y., Mao C. DNA nanotubes as combinatorial vehicles for cellular delivery. Biomacromolecules 2008, 9:3039-3043.
21. Chou L.Y., Zagorovsky K., Chan W.C. DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat. Nanotechnol. 2014, 9:148-155.
22. Fakhoury J.J., McLaughlin C.K., Edwardson T.W., Conway J.W., Sleiman H.F. Development and characterization of gene silencing DNA cages. Biomacromolecules 2014, 15:276-282.
23. Wollman A.J., Sanchez-Cano C., Carstairs H.M., Cross R.A., Turberfield A.J. Transport and self-organization across different length scales powered by motor proteins and programmed by DNA. Nat. Nanotechnol. 2014, 9:44-47.
24. Pei H., Liang L., Yao G., Li J., Huang Q., Fan C. Reconfigurable three-dimensional DNA nanostructures for the construction of intracellular logic sensors. Angew. Chem. Int. Ed. Engl. 2012, 51:9020-9024.
25. Kuzyk A., Schreiber R., Fan Z., Pardatscher G., Roller E.M., Hogele A., et al. DNA-based self-assembly of chiral plasmonic nanostructures with tailored optical response. Nature 2012, 483:311-314.
26. Huisman A.M., Vreugdenhil S.A., van Paassen H.C. Treatment of pulmonary arterial hypertension. N. Engl. J. Med. 2005, 352:308-309. author reply -9.
27. Ryan J.J., Marsboom G., Archer S.L. Rodent models of group 1 pulmonary hypertension. Handb. Exp. Pharmacol. 2013, 218:105-149.
28. Baliga R.S., MacAllister R.J., Hobbs A.J. New perspectives for the treatment of pulmonary hypertension. Br. J. Pharmacol. 2011, 163:125-140.
29. Goncharov D.A., Kudryashova T.V., Ziai H., Ihida-Stansbury K., DeLisser H., Krymskaya V.P., et al. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension. Circulation 2014, 129:864-874.
30. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
31. Mizumura K., Cloonan S.M., Haspel J.A., Choi A.M. The emerging importance of autophagy in pulmonary diseases. Chest 2012, 142:1289-1299.
32. Lee S.J., Smith A., Guo L., Alastalo T.P., Li M., Sawada H., et al. Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2011, 183:649-658.
33. Knuppertz L., Hamann A., Pampaloni F., Stelzer E., Osiewacz H.D. Identification of autophagy as a longevity-assurance mechanism in the aging model Podospora anserina. Autophagy 2014, 10:822-834.
34. Koren I., Kimchi A. Cell biology. Promoting tumorigenesis by suppressing autophagy. Science 2012, 338:889-890.
35. Wang D., Hiesinger P.R. Autophagy, neuron-specific degradation and neurodegeneration. Autophagy 2012, 8:711-713.
36. Ost A., Svensson K., Ruishalme I., Brannmark C., Franck N., Krook H., et al. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol. Med. 2010, 16:235-246.
37. Liao X., Sluimer J.C., Wang Y., Subramanian M., Brown K., Pattison J.S., et al. Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 2012, 15:545-553.
38. Jung C.H., Ro S.H., Cao J., Otto N.M., Kim D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
39. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
40. Xu L.Z., Long Z.J., Peng F., Liu Y., Xu J., Wang C., et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells. Oncotarget 2014, 5:7498-7511.
41. Yang Z., Ming X.F. mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases. Obes. Rev. 2012, 13(Suppl. 2):58-68.
42. Liu Y., Zhang D.T., Liu X.G. mTOR signaling in T cell immunity and autoimmunity. Int. Rev. Immunol. 2015, 34:50-66.
43. Cang C., Zhou Y., Navarro B., Seo Y.J., Aranda K., Shi L., et al. mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state. Cell 2013, 152:778-790.
44. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
45. Yin H., Kanasty R.L., Eltoukhy A.A., Vegas A.J., Dorkin J.R., Anderson D.G. Non-viral vectors for gene-based therapy. Nat. Rev. Genet. 2014, 15:541-555.
46. Gilleron J., Querbes W., Zeigerer A., Borodovsky A., Marsico G., Schubert U., et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 2013, 31:638-646.
47. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 2009, 8:129-138.
48. Liu X., Wang G., You Z., Qian P., Chen H., Dou Y., et al. Inhibition of hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by a mTOR siRNA-loaded cyclodextrin nanovector. Biomaterials 2014, 35:4401-4416.
49. Chen H., Liu X., Dou Y., He B., Liu L., Wei Z., et al. A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials 2013, 34:4159-4172.
50. You Z., Qian H., Wang C., He B., Yan J., Mao C., Wang G. Inhibition of DNA nanotube-conjugated mTOR siRNA on the growth of pulmonary arterial smooth muscle cells. Data in Brief 2015, (in press).
51. Hunter A.C., Moghimi S.M. Cationic carriers of genetic material and cell death: a mitochondrial tale. Biochim. Biophys. Acta 2010, 1797:1203-1209.
52. Kanasty R., Dorkin J.R., Vegas A., Anderson D. Delivery materials for siRNA therapeutics. Nat. Mater. 2013, 12:967-977.
53. Safinya C.R., Ewert K.K., Majzoub R.N., Leal C. Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. New J. Chem. 2014, 38:5164-5172.
54. Junquera E., Aicart E. Cationic lipids as transfecting agents of DNA in gene therapy. Curr. Top. Med. Chem. 2014, 14:649-663.
55. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. 2002, 16:1217-1226.
56. Andersen E.S., Dong M., Nielsen M.M., Jahn K., Subramani R., Mamdouh W., et al. Self-assembly of a nanoscale DNA box with a controllable lid. Nature 2009, 459:73-76.
57. Li J., Pei H., Zhu B., Liang L., Wei M., He Y., et al. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano 2011, 5:8783-8789.
58. Qian H., Tian C., Yu J., Guo F., Zheng M.S., Jiang W., et al. Self-assembly of DNA nanotubes with defined diameters and lengths. Small 2014, 10:855-858.
59. Ui-Tei K., Naito Y., Zenno S., Nishi K., Yamato K., Takahashi F., et al. Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect. Nucleic Acids Res. 2008, 36:2136-2151.
60. Hong C.A., Jang B., Jeong E.H., Jeong H., Lee H. Self-assembled DNA nanostructures prepared by rolling circle amplification for the delivery of siRNA conjugates. Chem. Commun. (Camb) 2014, 50:13049-13051.
61. Prabha S., Zhou W.Z., Panyam J., Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 2002, 244:105-115.
62. Gao H., Shi W., Freund L.B. Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9469-9474.
63. Bae Y.M., Park Y.I., Nam S.H., Kim J.H., Lee K., Kim H.M., et al. Endocytosis, intracellular transport, and exocytosis of lanthanide-doped upconverting nanoparticles in single living cells. Biomaterials 2012, 33:9080-9086.
64. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2:1639-1644.
65. Langecker M., Arnaut V., List J., Simmel F.C. DNA nanostructures interacting with lipid bilayer membranes. Acc. Chem. Res. 2014, 47:1807-1815.
66. Bennett M.R., Gibson D.F., Schwartz S.M., Tait J.F. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ. Res. 1995, 77:1136-1142.
67. Panyam J., Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 2003, 20:212-220.
68. Reddy M.K., Vasir J.K., Sahoo S.K., Jain T.K., Yallapu M.M., Labhasetwar V. Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured artery. Circ. Cardiovasc. Interv. 2008, 1:209-216.
69. Shan J., Nguyen T.B., Totary-Jain H., Dansky H., Marx S.O., Marks A.R. Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19006-19011.
70. Hegner B., Lange M., Kusch A., Essin K., Sezer O., Schulze-Lohoff E., et al. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Arterioscler. Thromb. Vasc. Biol. 2009, 29:232-238.
71. Kim J.S., Kim I.K., Lee S.Y., Song B.W., Cha M.J., Song H., et al. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. Cell Biol. Int. 2012, 36:305-310.
72. Zhang H., Gong Y., Wang Z., Jiang L., Chen R., Fan X., et al. Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia. J. Cell Mol. Med. 2014, 18:542-553.
73. Jahreiss L., Menzies F.M., Rubinsztein D.C. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic 2008, 9:574-587.
74. Hoyer-Hansen M., Bastholm L., Szyniarowski P., Campanella M., Szabadkai G., Farkas T., et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol. Cell 2007, 25:193-205.
75. Andon F.T., Fadeel B. Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. 2013, 46:733-742.
76. Wu L., Zhang Y., Zhang C., Cui X., Zhai S., Liu Y., et al. Tuning cell autophagy by diversifying carbon nanotube surface chemistry. ACS Nano 2014, 8:2087-2099.
77. Ganley I.G., Lam du H., Wang J., Ding X., Chen S., Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009, 284:12297-12305.
78. Krymskaya V.P., Snow J., Cesarone G., Khavin I., Goncharov D.A., Lim P.N., et al. mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia. FASEB J. 2011, 25:1922-1933.
79. Huang H., Zhang P., Wang Z., Tang F., Jiang Z. Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease. Circ. J. 2011, 75:1463-1471.
80. Houssaini A., Abid S., Mouraret N., Wan F., Rideau D., Saker M., et al. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2013, 48:568-577.